Veera Ojala
vekaoj@utu.fi +358 29 450 3786 +358 50 354 1288 Tykistökatu 6 Turku |
- De Novo Multi-Omics Pathway Analysis Designed for Prior Data Independent Inference of Cell Signaling Pathways (2024)
- Molecular and Cellular Proteomics
- ERBB4 as a potential therapeutic target in cancer (2024) Ojala, Veera
- Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth in vivo (2024)
- ChemBioChem
- An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations (2022)
- Cancer Research Communications
- Therapeutic Potential of Targeting the SUMO Pathway in Cancer (2021)
- Cancers
- The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration (2020)
- Journal of Biological Chemistry
- An unbiased in vitro screen for activating epidermal growth factor receptor mutations (2019)
- Journal of Biological Chemistry
- Genome-wide screen of gamma-secretase-mediated intramembrane cleavage of receptor tyrosine kinases (2017)
- Molecular Biology of the Cell